Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Synthesis of (Imido)vanadium(V) Complexes Containing 8‑(2,6-Dimethylanilide)-5,6,7-trihydroquinoline Ligands: Highly Active Catalyst Precursors for Ethylene Dimerization by Xiao-Yan Tang (147869)

“…A series of (imido)­vanadium­(V) dichloride complexes containing 8-(2,6-dimethylanilide)-5,6,7-trihydroquinoline ligands of the type V­(NR)­Cl₂[8-(2,6-Me₂C₆H₃)­N­(C₉H₁₀N)] (R = Ad (<b>3</b>), 2-MeC₆H₄ (<b>4</b>), 2,6-Me₂C₆H₃ (Ar, <b>5</b>)) have been prepared and identified, and their structures have been determined by X-ray crystallographic analysis. …”

Protection of Aβ-mediated neuronal cell death by sRAGE, pyridoxamine or ALT-711 through decreasing RAGE levels. by Kyunghee Byun (162379)

“…(C) Triple confocal microscopic images simultaneously show the relative numbers of AGE, albumin, or Iba1 positive cells in the rat entorhinal cortex (EC) before or after Aβ or Aβ/sRAGE injection for 72 h. These results represent similar images of 5 independent analyses. …”

Presentation 1_Prehospital tranexamic acid decreases early mortality in trauma patients: a systematic review and meta-analysis.pdf by Yi Li (1144)

“…Data were pooled under a random- or fixed-effects model using RevMan 5.4 with odds ratio (OR) and 95% confidence interval (CI) as the effect measures.…”

List of the main semi-quantified compounds (% area) from pyrolysis of A, M2.5, M5, M10 at 450ºC, 550º and 650ºC. by Sueilha F. A. Paula (13988800)

Description of columns in S5 Table. by Thomas J. C. Sauters (17382864)

sEH deficiency decreases cerulein-induced pancreatic injury. by Ahmed Bettaieb (173694)

Cell proliferation is significantly decreased by age in the mouse hippocampal DG. by Joana Gil-Mohapel (462002)

HT decreases the oxidative stress level only in hypoxic conditions. by Jesús Calahorra (5774630)

miR-153 was decreased in osteosarcoma tissues and cell line. by Guangfeng Niu (707090)

Delayed graft function is associated with decreased peritubular capillary density. by Shaynah Wanga (797013)

“…There is an evident decrease in the abundance and density of the peritubular capillaries, particularly in a patchy, non-uniform distribution (arrows). …”

Comparison of wind roses between ERA5 reanalysis and in-situ measured data. a: W03 station, b: W08 station, c: W13 station and d: W19 station. by Weidong Ji (129916)

Expression of WT Dyskerin can rescue dysfunctional telomerase in <i>ΔL37</i> cells but not in <i>A353V</i> cells. by Bai-Wei Gu (740949)

Neuronal differentiation is significantly decreased by age in the mouse hippocampal DG. by Joana Gil-Mohapel (462002)

Image2_A Novel Plant Leaf Patch Absorbed With IL-33 Antibody Decreases Venous Neointimal hyperplasia.TIFF by Boao Xie (11621803)

“…IL-33 plays a role in venous neointimal hyperplasia both in humans and rats; neutralization of IL-33 by IL-33 antibody can be a therapeutic method to decrease venous neointimal hyperplasia.…”

Image1_A Novel Plant Leaf Patch Absorbed With IL-33 Antibody Decreases Venous Neointimal hyperplasia.TIFF by Boao Xie (11621803)

“…IL-33 plays a role in venous neointimal hyperplasia both in humans and rats; neutralization of IL-33 by IL-33 antibody can be a therapeutic method to decrease venous neointimal hyperplasia.…”

Decreased proliferation and change in physical properties of mutant optic vesicle. by Anna-Carin Hägglund (90431)

AvcD is activated by T5 and T7 phages. by Brian Y. Hsueh (16955722)

Down-regulation of nucleolin expression decreases binding to human monocytes. by Monique Barel (236154)

Viability of microencapsulated FP ICCs decreased with time post-transplantation. by Vijayaganapathy Vaithilingam (390354)

“…<p>A) Fluorescent images of encapsulated FP ICCs stained with 6-CFDA for viable cells (green) and PI for non-viable cells (red) to assess viability at (A) pre-transplantation, (B) day 1, (C) day 3, (D) day 7, (E) day 14 and (F) day 21 post-transplantation. …”